↓ Skip to main content

Estrogen for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, October 2005
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (57th percentile)

Mentioned by

twitter
5 tweeters

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
103 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Estrogen for schizophrenia
Published in
Cochrane database of systematic reviews, October 2005
DOI 10.1002/14651858.cd004719.pub2
Pubmed ID
Authors

Wan Lian LC Chua, Angelica Izquierdo de Santiago, Jayashri Kulkarni, Ann Mortimer

Abstract

In terms of clinical outcomes, women with schizophrenia seem to fare better then men, but appear more vulnerable to psychotic illness in the period after birth and menopause. As these vulnerable periods to psychosis are associated with estrogen withdrawal, this hormone has been proposed as a treatment for schizophrenia.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 103 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 17%
Student > Bachelor 16 16%
Researcher 12 12%
Student > Doctoral Student 11 11%
Student > Ph. D. Student 10 10%
Other 22 21%
Unknown 14 14%
Readers by discipline Count As %
Medicine and Dentistry 38 37%
Psychology 25 24%
Nursing and Health Professions 9 9%
Social Sciences 4 4%
Biochemistry, Genetics and Molecular Biology 3 3%
Other 7 7%
Unknown 17 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2016.
All research outputs
#6,743,710
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#6,829
of 8,923 outputs
Outputs of similar age
#60,210
of 143,119 outputs
Outputs of similar age from Cochrane database of systematic reviews
#68
of 93 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 45th percentile – i.e., 45% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 143,119 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.
We're also able to compare this research output to 93 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.